Jacques-Pierre Moreau

In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogue

John E. Taylor, Arthur E. Bogdén, Jacques-Pierre Moreau et al. · Biochemical and Biophysical Research Communications · 1988 · 128 citations

Vivo Inhibition, Oncogenic Agent, Medicine +10

Suppression of Rat and Human Growth Hormone and Prolactin Secretion by a Novel Somatostatin/Dopaminergic Chimeric Ligand

Song-Guang Ren, Sun H. Kim, John E. Taylor et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 86 citations · Full text

Pituitary Gh Secretion, Human Growth, Immunology +17

Amelioration of Chemotherapy‐Induced Toxicity by Cotreatment with AcSDKP, a Tetrapeptide Inhibitor of Hematopoietic Stem Cell Proliferation

Arthur E. Bogdén, Patrice Carde, E. Deschamps de Paillette et al. · Annals of the New York Academy of Sciences · 1991 · 57 citations

Chemotherapy‐induced Toxicity, Oncology, Tetrapeptide Inhibitor +7

Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration.

Arthur E. Bogdén, John E. Taylor, Jacques-Pierre Moreau et al. · PubMed · 1990 · 41 citations

Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF

Arthur E. Bogdén, Jacques-Pierre Moreau, Christina Gamba‐Vitalo et al. · International Journal of Cancer · 1998 · 16 citations

Immunology, Immunotherapy, Myelopoietic Response +21